Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1954 studies found for:    alzheimer
Show Display Options
RSS Create an RSS feed from your search for:
alzheimer
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
21 Completed Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: donepezil
22 Recruiting Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Mild to Moderate Alzheimer's Disease
Intervention: Drug: Rivastigmine Patch
23 Completed
Has Results
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg;   Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 200 mg/kg;   Biological: Placebo solution: Human Albumin 0.25% - 4 mL/kg;   Biological: Placebo solution: Human Albumin 0.25% - 2 mL/kg
24 Recruiting A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: CAD106 Immunotherapy;   Other: Placebo to CAD106;   Drug: CNP520;   Other: Placebo to CNP520
25 Recruiting The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
26 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
27 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
28 Recruiting Study to Evaluate Coconut Oil for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Coconut Oil Beverage;   Other: Placebo Beverage
29 Recruiting A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
30 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
31 Completed
Has Results
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Condition: Alzheimer's Disease
Interventions: Behavioral: Individualized management of AD including caregiver training;   Drug: Memantine
32 Completed A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
33 Unknown  Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: 3APS
34 Completed Life From Vision in Alzheimer Disease
Conditions: Alzheimer Disease;   Cataract
Intervention: Behavioral: Questionaries
35 Unknown  Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
Condition: Alzheimer's Dementia
Intervention: Device: Resonator
36 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
37 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
38 Completed Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
39 Completed Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: AADvac1;   Other: Placebo
40 Enrolling by invitation EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Procedure: ERP/EEG test;   Procedure: Psychometric testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.